FDA authorizes updated COVID-19 vaccines for upcoming season

The FDA has approved updated 2026-2027 COVID-19 vaccines from Pfizer/BioNTech, Moderna, Sanofi, and Takeda. These reformulated immunizations target the XFG variant, preparing for the fall respiratory virus season. This approval provides the public with new tools to protect against evolving COVID-19 strains, based on extensive clinical and real-world data.